Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer

Yamac D., Ozturk B., Coskun U., Tekin E., Sancak B., YILDIZ R., ...Daha Fazla

ADVANCES IN THERAPY, cilt.25, sa.8, ss.801-809, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 8
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1007/s12325-008-0082-2
  • Dergi Adı: ADVANCES IN THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.801-809
  • Gazi Üniversitesi Adresli: Evet

Özet

Introduction: YKL-40 is a growth factor for connective tissue cells; it also stimulates the migration of endothelial cells. YKL-40 is secreted by cancer cells, and elevated serum levels have been associated with poorer prognosis in metastatic breast cancer. In the present study we evaluated the prognostic role of serum YKL-40 levels in patients with locally advanced breast cancer.